Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06184295

Robotic Balance Training to Improve Postural Control and Balance Post-Traumatic Brain Injury

Robotic Balance Training to Improve Postural Control and Balance Post-Traumatic Brain

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Kessler Foundation · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess a balance training program to see if it can be helpful to improve balance and avoid falls in people who have had traumatic brain injuries (TBIs). The study will involve three groups of research subjects: 1) TBI-intervention group, 2) TBI- non-intervention group and 3) the participants without disability group. The TBI intervention Group will participate in 10 robotic balance training sessions. Data will collected pre and post-training. TBI- non-intervention group will not receive any training. They will participate in two data collection sessions which are about 5 weeks apart. The participants without disability group will not receive any training. They will participate in one data collection session.

Conditions

Interventions

TypeNameDescription
DEVICETBI - Intervention GroupThe participants will receive 10 customized robotic balance training sessions to improve balance using the Hunova robotic device. Each session will last for up to 1.5 hours. The training may include standing or sitting on the robotic balance platform and performing the following tasks: maintaining balance when the platform becomes unstable or moving in various directions, or in an inclination; these tasks may be performed as instructed with eyes open or eyes closed condition; move in different directions to reach targets with my hands; stand on one leg or heel to toe and maintain balance; perform head or torso rotation while standing or sitting. All training will be performed with an overhead harness and a spotter will be present at all times.

Timeline

Start date
2024-01-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-12-28
Last updated
2024-12-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06184295. Inclusion in this directory is not an endorsement.